Interleukin 18 Inhibits Osteoclast Formation Via T Cell Production of Granulocyte Macrophage Colony-stimulating Factor

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1998 Mar 21

PMID 9449693

Citations 40

Authors

N J Horwood

N Udagawa

J Elliott

D Grail

H Okamura

M Kurimoto

A R Dunn

T Martin

M T Gillespie

Affiliations

Soon will be listed here.

Abstract

IL-18 inhibits osteoclast (OCL) formation in vitro independent of IFN-gamma production, and this was abolished by the addition of neutralizing antibodies to GM-CSF. We now establish that IL-18 was unable to inhibit OCL formation in cocultures using GM-CSF-deficient mice (GM-CSF -/-). Reciprocal cocultures using either wild-type osteoblasts with GM-CSF -/- spleen cells or GM-CSF -/- osteoblasts with wild-type spleen cells were examined. Wild-type spleen cells were required to elicit a response to IL-18 indicating that cells of splenic origin were the IL-18 target. As T cells comprise a large proportion of the spleen cell population, the role of T cells in osteoclastogenesis was examined. Total T cells were removed and repleted in various combinations. Addition of wild-type T cells to a GM-CSF -/- coculture restored IL-18 inhibition of osteoclastogenesis. Major subsets of T cells, CD4+ and CD8+, were also individually depleted. Addition of either CD4+ or CD8+ wild-type T cells restored IL-18 action in a GM-CSF -/- background, while IL-18 was ineffective when either CD4+ or CD8+ GM-CSF -/- T cells were added to a wild-type coculture. These results highlight the involvement of T cells in IL-18-induced OCL inhibition and provide evidence for a new OCL inhibitory pathway whereby IL-18 inhibits OCL formation due to action upon T cells promoting the release of GM-CSF, which in turn acts upon OCL precursors.

Citing Articles

Wang H, Li Y, Li H, Yan X, Jiang Z, Feng L J Orthop Translat. 2025; 51:82-93.

PMID: 39991456 PMC: 11847249. DOI: 10.1016/j.jot.2024.12.004.

Exploring the Role of Hormones and Cytokines in Osteoporosis Development.

Umur E, Bulut S, Yigit P, Bayrak E, Arkan Y, Arslan F Biomedicines. 2024; 12(8).

PMID: 39200293 PMC: 11351445. DOI: 10.3390/biomedicines12081830.

The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis: a review.

Xu J, Yu L, Liu F, Wan L, Deng Z Front Immunol. 2023; 14:1222129.

PMID: 37475866 PMC: 10355373. DOI: 10.3389/fimmu.2023.1222129.

Associations of IL-18 with Altered Cardiovascular Risk Profile in Psoriatic Arthritis and Ankylosing Spondylitis.

Bonek K, Kuca-Warnawin E, Kornatka A, Zielinska A, Wislowska M, Kontny E J Clin Med. 2022; 11(3).

PMID: 35160217 PMC: 8836492. DOI: 10.3390/jcm11030766.

Macrophage-Osteoclast Associations: Origin, Polarization, and Subgroups.

Sun Y, Li J, Xie X, Gu F, Sui Z, Zhang K Front Immunol. 2021; 12:778078.

PMID: 34925351 PMC: 8672114. DOI: 10.3389/fimmu.2021.778078.

References

Chambers T, Revell P, Fuller K, Athanasou N . Resorption of bone by isolated rabbit osteoclasts. J Cell Sci. 1984; 66:383-99. DOI: 10.1242/jcs.66.1.383. View

Matsumoto S, Aizawa Y, Koide K, Takeuchi M, Ohta T, Kurimoto M . Interleukin-18 activates NF-kappaB in murine T helper type 1 cells. Biochem Biophys Res Commun. 1997; 234(2):454-7. DOI: 10.1006/bbrc.1997.6665. View

Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S . Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Endocrinology. 1988; 123(5):2571-7. DOI: 10.1210/endo-123-5-2571. View

Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley J . Osteoblastic cells are involved in osteoclast formation. Endocrinology. 1988; 123(5):2600-2. DOI: 10.1210/endo-123-5-2600. View

Udagawa N, Takahashi N, Akatsu T, Sasaki T, Yamaguchi A, Kodama H . The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology. 1989; 125(4):1805-13. DOI: 10.1210/endo-125-4-1805. View

Rosen C, Usiskin K, Owens M, Barlascini C, BELSKY M, Adler R . T lymphocyte surface antigen markers in osteoporosis. J Bone Miner Res. 1990; 5(8):851-5. DOI: 10.1002/jbmr.5650050808. View

Metcalf D, Nicola N . The clonal proliferation of normal mouse hematopoietic cells: enhancement and suppression by colony-stimulating factor combinations. Blood. 1992; 79(11):2861-6. View

Hustmyer F, Walker E, Yu X, Girasole G, Sakagami Y, Peacock M . Cytokine production and surface antigen expression by peripheral blood mononuclear cells in postmenopausal osteoporosis. J Bone Miner Res. 1993; 8(1):51-9. DOI: 10.1002/jbmr.5650080108. View

Stanley E, Lieschke G, Grail D, Metcalf D, Hodgson G, Gall J . Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci U S A. 1994; 91(12):5592-6. PMC: 44042. DOI: 10.1073/pnas.91.12.5592. View

10.

Cline M . Histiocytes and histiocytosis. Blood. 1994; 84(9):2840-53. View

11.

Martin T, Ng K . Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity. J Cell Biochem. 1994; 56(3):357-66. DOI: 10.1002/jcb.240560312. View

12.

Serrano S, Marinoso M, Soriano J, Rubies-Prat J, Aubia J, Coll J . Bone remodelling in human immunodeficiency virus-1-infected patients. A histomorphometric study. Bone. 1995; 16(2):185-91. DOI: 10.1016/8756-3282(94)00028-x. View

13.

Robb L, Drinkwater C, Metcalf D, Li R, Kontgen F, Nicola N . Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. Proc Natl Acad Sci U S A. 1995; 92(21):9565-9. PMC: 40842. DOI: 10.1073/pnas.92.21.9565. View

14.

Okamura H, Tsutsi H, Komatsu T, Yutsudo M, HAKURA A, Tanimoto T . Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature. 1995; 378(6552):88-91. DOI: 10.1038/378088a0. View

15.

Buchinsky F, Ma Y, MANN G, Rucinski B, Bryer H, Paynton B . Bone mineral metabolism in T lymphocyte-deficient and -replete strains of rat. J Bone Miner Res. 1995; 10(10):1556-65. DOI: 10.1002/jbmr.5650101018. View

16.

Buchinsky F, Ma Y, MANN G, Rucinski B, Bryer H, Romero D . T lymphocytes play a critical role in the development of cyclosporin A-induced osteopenia. Endocrinology. 1996; 137(6):2278-85. DOI: 10.1210/endo.137.6.8641176. View

17.

John V, Hock J, Short L, Glasebrook A, Galvin R . A role for CD8+ T lymphocytes in osteoclast differentiation in vitro. Endocrinology. 1996; 137(6):2457-63. DOI: 10.1210/endo.137.6.8641199. View

18.

USHIO S, Namba M, Okura T, Hattori K, Nukada Y, Akita K . Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol. 1996; 156(11):4274-9. View

19.

Micallef M, Ohtsuki T, Kohno K, Tanabe F, USHIO S, Namba M . Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur J Immunol. 1996; 26(7):1647-51. DOI: 10.1002/eji.1830260736. View

20.

Li P, Allen H, Banerjee S, Seshadri T . Characterization of mice deficient in interleukin-1 beta converting enzyme. J Cell Biochem. 1997; 64(1):27-32. DOI: 10.1002/(sici)1097-4644(199701)64:1<27::aid-jcb5>3.0.co;2-1. View